Peru DIGEMID registration DMDIV4778E

BILIRUBIN DPD DIRECT, BILIRUBIN DPD TOTAL, BRAND: QCA

Local name: BILIRRUBINA DPD DIRECTA, BILIRRUBINA DPD TOTAL, MARCA: QCA

Peru·IN VITRO MEDICAL DEVICE·APPLIED CLINICAL CHEMISTRY S.A.·Registered December 28, 2022

Device classification

Product Type: IN VITRO MEDICAL DEVICE

Registration information

Analysis ID: DMDIV4778E
Registration Date: December 28, 2022
Expiration Date: December 28, 2027
Creation Date: March 10, 2025

Manufacturer

Name: APPLIED CLINICAL CHEMISTRY S.A.

Authorized Representative

Name: CORPORACION JEM BIOS E.I.R.L.

About this record

Access comprehensive regulatory information for BILIRUBIN DPD DIRECT, BILIRUBIN DPD TOTAL, BRAND: QCA in the Peru medical device market through Pure Global AI's free database. This medical device is registered under DIGEMID ID DMDIV4778E and manufactured by APPLIED CLINICAL CHEMISTRY S.A.. The device was registered on December 28, 2022.

This page provides complete registration details including product type (IN VITRO MEDICAL DEVICE), manufacturer information, authorized representative details, and regulatory compliance data from the official Peru DIGEMID medical device database. Pure Global AI offers free access to Peru's complete medical device registry.